August 4, 2021 Inogen Announces Second Quarter 2021 Financial Results – Q2 2021 Record Total Revenue of $101.6 million, up 41.7% from the same period in 2020 – GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended June 30, 2021. Second Quarter 2021 Highlights Total revenue of $101.6 million, up 41.7% from the same period in 2020, primaril ...

Inogen, Inc. (NASDAQ:INGN) Q2 2021 Earnings Conference Call May 4, 2021 4:30 PM ET Company Participants Jason Somer - Executive Vice President & General Counsel Nabil Shabshab - President & Chief Executive Officer Alison Bauerlein - Founder, Chief Financial Officer & Executive Vice President, Finance Conference Call Participants Margaret Kaczor - William Blair Brett Fishbin - KeyBanc Lilia - JP Morgan Rebecca Wang - SVB Leerink Mike Matson - Needham & Company Operator Greetings, and welcome to the Inogen's ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) Delaware 33-0989359 ( State or other jurisdiction of i ...

Inogen, Inc Overview May 2021 Notice Regarding Forward-Looking Statements 1 These slides and the accompanying oral presentation (the "Presentation") include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on current expectations, estimates and projections based on information currently available to management. These forward-looking statements include, among others, statements relating to our business strategy; our expectations regarding ...

Inogen, Inc. (NASDAQ:INGN) Q1 2021 Earnings Conference Call May 4, 2021 4:30 PM ET Company Participants Ali Bauerlein - Chief Financial Officer and Co-Founder Nabil Shabshab - President and Chief Executive Officer Conference Call Participants Matthew Mishan - KeyBanc Margaret Kaczor - William Blair Robbie Marcus - JPMorgan Mike Matson - Needham and Company Rebecca Wang - SVB Leerink Operator Greetings, and welcome to the Inogen's First Quarter 2021 Financial Results Conference Call. At this time, all partic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) Delaware 33-0989359 ( State or other jurisdiction of ...

Company Overview February 2021 Notice Regarding Forward-Looking Statements 2 These slides and the accompanying oral presentation (the "Presentation") include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on current expectations, estimates and projections based on information currently available to management. These forward-looking statements include, among others, statements relating to our business strategy; our expectations regarding ...

Inogen, Inc. (NASDAQ:INGN) Q4 2020 Earnings Conference Call February 24, 2021 4:30 PM ET Company Participants Matt Pigeon – Investor Relations Nabil Shabshab – President and Chief Executive Officer Ali Bauerlein – Chief Financial Officer and Co-Founder Conference Call Participants Robbie Marcus – JP Morgan Matthew Mishan – KeyBanc Joseph Conway – Needham Brandon Vazquez – William Blair Rebecca Wang – SVB Leerink Operator Greetings, and welcome to the Inogen's Fourth Quarter and Year-End 2020 Earnings Confer ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) | Delaware | 33-0989359 | | --- | --- | | State or other jurisdiction ...

Company Overview November 2020 Notice regarding forward-looking statements 2 These slides and the accompanying oral presentation (the "Presentation") include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on current expectations, estimates and projections based on information currently available to management. These forward-looking statements include, among others, statements relating to our expectations regarding changing reimbursement ...